NGM Biopharmaceuticals Price on June 30, 2023

NGM Biopharmaceutica Valuation on June 30, 2023

NGM Biopharmaceutica Trading Date Momentum on June 30, 2023

On July 03 2023 NGM Biopharmaceuticals was traded for  2.70  at the closing time. Highest NGM Biopharmaceutica's price during the trading hours was 2.71  and the lowest price during the day was  2.52 . The net volume was 189.1 K. The overall trading history on the 3rd of July contributed to the next trading period price boost. The trading delta at closing time to the next next day price was 4.25% . The trading delta at closing time to current price is 6.18% .

NGM Biopharmaceuticals Fundamentals Correlations and Trends

By evaluating NGM Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NGM Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NGM financial account trend analysis is a perfect complement when working with valuation or volatility modules.

NGM Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NGM Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NGM Biopharmaceutica stock prices may prove useful in developing a viable investing in NGM Biopharmaceutica

NGM Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.

Market strength indicators help investors to evaluate how NGM Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NGM Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying NGM Biopharmaceutica stock market strength indicators, traders can identify NGM Biopharmaceuticals entry and exit signals to maximize returns

Predictive indicators are helping investors to find signals for NGM Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of NGM Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NGM to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.